II will be surprised if IBX runs the pivotal study. I think they will partner up with a major company and license out the technology. The major partner will then run the study without eroding cash. Imagion can then focus on R&D. For instance, develop thenon invasive prostate detection test.
read that latest imagion post and you have many answers, page-6
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.318M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 543 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 1358 | 1 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| IBX (ASX) Chart |
Day chart unavailable